1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Variability in the precore and core promoter region of the hepatitis B virus genome.
- Contribution to journal › Article
- 2011
-
Mark
SMAD4 binds HOXA9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by HOXA9 and leukemia transformation.
- Contribution to journal › Article
- 2010
-
Mark
SMAD4 Sequestrates HOXA9 to Protect Hematopoietic Stem Cells Against Leukemia Transformation
(2010) 52nd Annual Meeting of the American-Society-of-Hematology (ASH) In Blood 116(21). p.1297-1298
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
SMAD4 as a therapeutic target in hoxa9-related leukemia
(2009) 38th Annual Scientific Meeting of the ISEH-Society-for-Hematology-and-Stem-Cells In Experimental Hematology 37(9). p.44-45
- Contribution to journal › Published meeting abstract
- 2006
-
Mark
Novel mutation in Hepatitis B virus preventing HBeAg production and resembling primate strains.
- Contribution to journal › Article
-
Mark
High levels of hepatitis B virus DNA in body fluids from chronic carriers.
- Contribution to journal › Article
